What does Design Therapeutics, Inc. do?
Design Therapeutics, Inc. a clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited…
What is Design Therapeutics, Inc.'s P/E and P/B ratio?
Design Therapeutics, Inc. has a P/E ratio of -8.9 and a P/B ratio of 3.25.
What is Design Therapeutics, Inc.'s debt-to-equity ratio?
Design Therapeutics, Inc. has a debt-to-equity ratio of 0.01.
How much does Design Therapeutics, Inc. owe compared with what it owns?
Design Therapeutics, Inc. owes $0.06 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Design Therapeutics, Inc.'s Positivity rank?
Design Therapeutics, Inc. is ranked #3,412 of 6,774 companies globally and #1,451 of 4,000 in United States on PositoAI, with a Positivity Score of 20,586.
Does Design Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Design Therapeutics, Inc..
Where can I read the latest news about Design Therapeutics, Inc.?
Recent headlines about Design Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Design Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Design Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.